Dear Friends and Colleagues,
The Cardiovascular and Metabolic Disorders (CVMD) Programme is one of five Signature Research Programmes at Duke-NUS. Since its inception, the Programme has flourished under the visionary leadership of Professors Thomas Coffman, Stuart Cook and David Silver, evolving into a dynamic hub of innovation and discovery.
Today, our research encompasses a remarkable breadth of cardiovascular and metabolic biology and diseases. Our work ranges from fundamental scientific discoveries to cutting-edge translational research, with impactful clinical applications. Our faculty members are internationally recognised leaders in diverse fields, including lipid and fat cell biology, vascular biology, mitochondrial regulation, diabetes and kidney disease, heart development and failure, human genetics and clinical trials, as well as systems biology and computational biology.
At the heart of our Programme is a shared mission: To advance human cardiovascular and metabolic health. We achieve this by deepening scientific understanding and driving innovation to improve medicine. Our vibrant and highly collaborative research environment is supported by extensive core facilities and enriched through programme-sponsored academic activities, such as seminars and retreats.
The CVMD Programme is proud to be part of the joint National Heart Research Institute, fostering close collaboration with our partner, the National Heart Centre Singapore. Beyond our primary faculty, we maintain strong connections with the Centres for Computation Biology and Vision Research, enhancing our interdisciplinary capabilities. The CVMD Programme also interacts extensively with our academic partners from the Cardiovascular Research Institute (CVRI) and Molecular and Physiology Institute (MPI) at Duke University, USA, and the Yong Loo Lin School of Medicine at the National University of Singapore.
In addition to our research endeavours, we are deeply committed to training and education. Our faculty actively mentor medical and graduate students, alongside a significant number of research fellows, shaping the next generation of scientific leaders.
Welcome to the CVMD Programme—where collaboration meets innovation, and discovery drives impact.
Professor Yibin Wang
Director
Cardiovascular & Metabolic Disorders Programme